Epigenomics (ECX) Q4 2020 Earnings Report
DE:ECX Q4 2020 EPS Results
- Actual EPS
- -EUR 8.58
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 28.05
DE:ECX Q4 2020 Revenue Results
- Actual Revenue
- EUR 301.00K
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +25.94%
Earnings Announcement Details
- Quarter
- Q4 2020
- Date
- 03/25/2021
- Time
- Before Open
- Conference Call
- Thursday, March 25, 2021
Q4 2020 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2020 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2020 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:ECX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Aug 12, 2026 | 2026 (Q2) | ―-0.14 | -0.23 | 37.28% (+0.09) | |
| Aug 06, 2025 | 2025 (Q2) | ―-0.23 | -0.91 | 74.40% (+0.68) | |
| May 07, 2025 | 2025 (Q1) | ―-2.92 | ― | ― | |
| Mar 20, 2025 | 2024 (Q4) | ―- | ― | ― | |
| Nov 06, 2024 | 2024 (Q3) | ―- | ― | ― | |
| Jul 22, 2024 | 2024 (Q2) | ―-0.89 | -3.03 | 70.53% (+2.14) | |
| May 08, 2024 | 2024 (Q1) | ―- | ― | ― | |
| Mar 14, 2024 | 2023 (Q4) | ―- | -7.95 | ― | |
| Nov 09, 2023 | 2023 (Q3) | ―- | -0.1 | ― | |
| Aug 10, 2023 | 2023 (Q2) | ―-3.03 | -1.56 | -93.98% (-1.47) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed